Clinical Trial Update: Stone and Laser Therapies Post-Market Study (SALT)

View source ↗

Summary

A post-market clinical trial update for SALT (NCT06982235) shows Boston Scientific is recruiting to study stone- and laser-therapy approaches in patients with B…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia
• Nephrolithiasis

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Benign Prostate Hypertrophy(BPH), Renal Calculi | Status: RECRUITING